Roche to buy U.S. biotech firm Seragon for $725 million
July 02, 2014 at 01:20 AM EDT
ZURICH (Reuters) - Roche said it will pay $725 million in cash to buy Seragon Pharmaceuticals, a privately-held biotech company which researches breast cancer treatments.
